Back
Pharvaris NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Buy
65
PHVS
Pharvaris NV
Last Price:
19.43
Seasonality Move:
-4.02%
Sell
27
PRQR
ProQR Therapeutics NV
Last Price:
1.74
Seasonality Move:
-2.94%
Buy
65
Pharvaris NV (PHVS)
is a Buy
Is Pharvaris NV a Buy, Sell or Hold?
- The current Pharvaris NV [PHVS] share price is $21.01. The Score for PHVS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- PHVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $1.79. The Score for PRQR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- PRQR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHVS Stock Price Chart
What is Pharvaris NV's stock price today?
-
The Pharvaris NV share price today is $21.01
The current trend is moderately bullish and PHVS is experiencing slight buying pressure.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $1.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing slight buying pressure.
PHVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.79 | Buy |
Relative Strength Index (14 RSI): | 61.34 | Buy |
Chaikin Money Flow: | 58646 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.83 - 20.39) | Buy |
Bollinger Bands (100): | (16.91 - 20.81) | Buy |
PRQR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 34.88 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.83 - 2.09) | Sell |
Bollinger Bands (100): | (1.74 - 2.02) | Sell |
PHVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.74 | Buy |
20-day SMA: | 19.28 | Buy |
50-day SMA: | 18.3 | Buy |
200-day SMA: | 22.13 | Sell |
8-day EMA: | 20.39 | Buy |
20-day EMA: | 19.57 | Buy |
50-day EMA: | 18.87 | Buy |
200-day EMA: | 19.69 | Buy |
PRQR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.83 | Sell |
20-day SMA: | 1.92 | Sell |
50-day SMA: | 1.92 | Sell |
200-day SMA: | 2 | Sell |
8-day EMA: | 1.83 | Sell |
20-day EMA: | 1.89 | Sell |
50-day EMA: | 1.91 | Sell |
200-day EMA: | 1.91 | Sell |
Pharvaris NV Earnings Growth & PHVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.55 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
Pharvaris NV Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProQR Therapeutics NV Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |